(PharmaNewsWire.Com, March 16, 2017 ) According to the report Asia-Pacific In-Vitro Fertilization Market, published by Market Data Forecast, the Asia-Pacific market is projected to reach USD 0.53 billion by 2021, at a CAGR of 18.40% from 2016 to 2021
In-vitro fertilization (IVF) involves the fertilization of ovum using laboratory settings followed by implantation into uterus. In-vitro fertilization is also known as assisted reproductive technology. The process involves the collection of matured healthy eggs and sperms from the partners, or known or anonymous donors. These eggs get fertilized using laboratory reagents & media and instruments. Fertilized eggs (embryos) are implanted into uterus for the development of embryo to child. One cycle of in-vitro fertilization takes around 10-15 days. IVF is most widely accepted method for the fertility treatments in clinical industry and helpful for the couples with infertility problems, LGBT communities, single mothers. The major product categories that assist in-vitro fertilization method include reagents & media (such as sperm processing media, embryo culture media) and instruments (cryosystems, sperm separation system).
Presence of huge number of in-vitro fertilization clinics, increasing fertility tourisms, growing adoption of in-vitro fertilization procedures, and rising government initiatives relating to the development of healthcare infrastructure in certain countries of Asia-Pacific (India, Japan & China) are driving the growth of In-vitro fertilization market in Asia-Pacific region. In addition, growing rate of polycystic ovarian syndrome (PCOS), rising surrogacy, and increasing number of assisted reproductive technologies (ART) in Asian countries (Australia, New Zealand) are further stimulating the growth of in-vitro fertilization market in Asia-Pacific region. However, emotional & physical factors, ethical issues pertaining to gender selection are restraining the growth of in-vitro fertilization market in Asia-Pacific region.
The In-Vitro Fertilization Market is segmented as following: Based on Reagents and Media: Introduction Embryo Culture Media Cryopreservation Media Sperm Processing Media Ovum Processing Media Based on Instruments: Introduction Imaging Systems Sperm Separation Systems Ovum Aspiration Pumps Incubators Micromanipulator Systems Cryosystems Other Instruments (Gas Analyzers, Laser Systems, Accessories) Based on Technology: Introduction Intra-Cytoplasmic Sperm Injection (ICSI) Pre-Implantation Genetic Diagnosis (PGD) Frozen Embryo Transfer/Replacement (FET/FER) Other Technologies Based on End Users: Introduction Fertility and Surgical Centers Hospitals and Research Laboratories Cryobanks
The major companies operating in the In-Vitro Fertilization Market are Cook Medical, Thermo Fisher Scientific, Inc. (U.S.), IVFtech ApS (Denmark), Vitrolife AB (Sweden), Irvine Scientific (U.S.), Genea Limited (Australia), Inc. EMD Serono, Inc. (U.S.), CooperSurgical, Inc. (U.S.), ESCO Micro Pte. Limited (Singapore), and The Baker Company, Inc. (U.S.).
The In-Vitro Fertilization Market study offers the following deliverables: Asia-Pacific, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics Study of the effect of exogenous and endogenous factors that affect the Asia-Pacific market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis Study the micro environment factors that determine the overall profitability of an Industry, using Porters five forces analysis for analysing the level of competition and business strategy development A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Medical Devices Segment:
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
